摘要
目的探讨分析桑菊清解汤治疗痰热壅肺型肺热病的临床效果。方法选取2017年4月至2019年4月东莞市桥头医院中医科收治的70例痰热壅肺型肺热病患者,采用随机数字表法分为两组,各35例。观察组男19例,女16例,年龄(43.6±5.4)岁;对照组男20例,女15例,年龄(43.7±5.3)岁。对照组静脉滴注头孢呋辛治疗,观察组在对照组基础上增加应用桑菊清解汤治疗,两组患者均连续治疗7 d。比较两组患者临床治疗效果、相关临床症状积分、治疗起效时间及不良反应发生情况。结果观察组治疗总有效率为91.4%(32/35),高于对照组71.4%(25/35),差异有统计学意义(χ^(2)=4.629,P<0.05)。观察组治疗后发热、咳嗽、胸痛等临床症状积分及治疗起效时间分别为(0.4±0.1)分、(0.6±0.3)分、(0.5±0.2)分、(1.6±0.4)d,均低于对照组(0.7±0.2)分、(1.0±0.4)分、(0.8±0.3)分、(2.3±0.8)d,差异均有统计学意义(均P<0.05)。观察组不良反应发生率为5.7%(2/35),低于对照组22.8%(8/35),差异有统计学意义(χ^(2)=4.200,P<0.05)。结论桑菊清解汤治疗痰热壅肺型肺热病,能够迅速起效,显著改善临床症状、提高临床治疗效果,降低相关不良反应发生率,具有更高的安全性,值得推广应用。
Objective To investigate the clinical effect of Sangju Qingjie decoction in the treatment of phlegm-heat obstructing lung type pyretic pulmonary disease.Methods From April 2017 to April 2019,70 patients with phlegm-heat obstructing lung type pyretic pulmonary disease in the Department of Traditional Chinese Medicine,Qiaotou Hospital of Dongguan were divided into an observation group(n=35)and a control group(n=35)with the random number table.In the observation group,there were 19 males and 16 females,with an age of(43.6±5.4)years old.In the control group,there were 20 males and 15 females,with an age of(43.7±5.3)years old.The patients in the control group were treated with cefuroxime intravenously,while the patients in the observation group were treated with Sangju Qingjie decoction on the basis of the control group.Both groups were treated continuously for 7 days.The differences of clinical therapeutic effect,related clinical symptom score,treatment onset time,and adverse reactions between the two groups were compared.Results The total effective rate of clinical treatment in the observation group was 91.4%(32/35),which was higher than 71.4%(25/35)in the control group(χ^(2)=4.629,P<0.05).The scores of clinical symptoms such as fever,cough,and chest pain after the treatment and the onset time of treatment in the observation group were(0.4±0.1)points,(0.6±0.3)points,(0.5±0.2)points,and(1.6±0.4)d,which were lower than those in the control group[(0.7±0.2)points,(1.0±0.4)points,(0.8±0.3)points,and(2.3±0.8)d],with statistically significant differences(all P<0.05).The incidence of adverse reactions in the observation group was lower than that in the control group[5.7%(2/35)vs.22.8%(8/35)](χ^(2)=4.200,P<0.05).Conclusions Sangju Qingjie decoction in the treatment of phlegm-heat obstructing lung type pyretic pulmonary disease can quickly take effect,obviously improve the clinical symptoms,improve the clinical treatment effect,reduce the incidence of related adverse reactions,has higher safety,and is worthy of popularization and application.
作者
杨果
莫焕霞
李敬华
Yang Guo;Mo Huanxia;Li Jinghua(Department of Traditional Chinese Medicine,Qiaotou Hospital of Dongguan,Dongguan 523523,China)
出处
《国际医药卫生导报》
2021年第16期2545-2547,共3页
International Medicine and Health Guidance News
关键词
桑菊清解汤
痰热壅肺型
肺热病
临床效果
Sangju Qingjie decoction
Phlegm-heat obstructing lung type
Pyretic pulmonary disease
Clinical effect
